Original Research ArticleInternational Journal of Basic & Clinical Pharmacology
Publication: Is pregabalin better than gabapentin in treatment of neuropathic pain? An observation-based study at tertiary care centre of North India
Int J Basic Clin Pharmacol. 2022;11(5):395-400.DOI10.18203/2319-2003.ijbcp20222133
Abstract
Background The present study was undertaken to assess the efficacy of pregabalin and gabapentin in treatment of neuropathic pain at a government tertiary care hospital of Uttar Pradesh, India. Due to indiscriminate use of drugs for treatment of neuropathic pain, selection of an effective drug is need of hour.
Methods Out of 130 patients, 62 patients were given pregabalin and 68 were given gabapentin. Douleur Neuropathique 4 questionnaire (DN4) which was used to diagnose patients of neuropathic pain. Efficacy of drug was based on their capability to decrease neuropathic pain at regular intervals.
Results On comparing the efficacy of drugs by their ability to decrease neuropathic pain, there was a significant difference when comparing pregabalin and gabapentin, pregabalin being statistically significant than gabapentin.
Conclusions On the basis present study efficacy of pregabalin 300 mg once daily brought better improvement of symptoms and sign than that of gabapentin 600 mg administered once daily dose. So pregabalin is a better drug than gabapentin.
Keywords
Affiliations
- Department of Pharmacology, MLN Medical College, Prayagraj, Uttar Pradesh, India
- Department of Medicine, MLN Medical College, Prayagraj, Uttar Pradesh, India
